ENDRA Life Sciences Inc. — Director's Dealing 2023

Feb 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2023-01-30

Reporting Person: Harsh Michael (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-30	Stock Options	$4.02	A	9634	Acquired	2033-01-30	Common Stock (9634)	Direct

Footnotes

F1: This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024.